Umeå University
printicon
Main menu hidden.
Staff photo Emma Nyman

Emma Nyman

Contact

E-mail
emma.nyman@umu.se
Phone

Works at

Affiliation
Affiliated as other position at Department of Public Health and Clinical Medicine Units: Section of Medicine
Location
3B, Norrlands universitetssjukhus, Vån 1 Umeå universitet, by1a, B41, NUS, 901 85 Umeå
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial
American Journal of Preventive Cardiology, Elsevier 2021, Vol. 7
Bengtsson, Anna; Norberg, Margareta; Ng, Nawi; et al.
Ultrasound measurements of subclinical carotid atherosclerosis: methodological and clinical studies
Umeå University medical dissertations, 2152
Nyman, Emma
Inter-sonographer reproducibility of carotid ultrasound plaque detection using Mannheim consensus in subclinical atherosclerosis
Clinical Physiology and Functional Imaging, John Wiley & Sons 2020, Vol. 40, (1) : 46-51
Nyman, Emma; Vanoli, Davide; Näslund, Ulf; et al.
Ultrasound risk marker variability in symptomatic carotid plaque: impact on risk reclassification and association with temporal variation pattern
The International Journal of Cardiovascular Imaging, Springer 2020, Vol. 36, (6) : 1061-1068
Stenudd, Isak; Sjödin, Elias; Nyman, Emma; et al.
Bilateral carotid intima media thickness (cIMT) and plaque measurements was stronger associated with cardiovascular risk factors than unilateral measurements: Results from the VIPVIZA trial
European Heart Journal, Oxford University Press 2019, Vol. 40 : 2036-2036
Lundgren, A.; Nyman, Emma; Norberg, Margareta; et al.
Classification of pronounced subclinical atherosclerosis: deep learning approach of carotid intima media ultrasound images is superior to clinical risk factors
European Heart Journal, Oxford University Press 2019, Vol. 40 : 2050-2050
Nyman, Emma; Karlsson, Mikael; Näslund, Ulf; et al.
Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial
The Lancet, Elsevier 2019, Vol. 393, (10167) : 133-142
Näslund, Ulf; Ng, Nawi; Lundgren, Anna; et al.
Risk marker variability in subclinical carotid plaques based on ultrasound is influenced by cardiac phase, echogenicity and size
Ultrasound in Medicine and Biology, Elsevier 2018, Vol. 44, (8) : 1742-1750
Nyman, Emma; Lindqvist, Per; Näslund, Ulf; et al.
Area measurement of carotid plaque comparing B-MODE, Doppler color and contrast-enhanced ultrasound imaging
Atherosclerosis, Elsevier 2016, Vol. 252 : E191-E191
Nyman, Emma; Vanoli, Davide; Grönlund, Christer; et al.
Carotid artery plaque assessment within the Västerbotten intervention programme: VIPVIZA
Atherosclerosis, Vol. 241, (1) : E159-E159
Nyman, Emma; Grönlund, Christer; Vanoli, Davide; et al.
Association of cardiovascular disease risk factors with combined carotid ultrasound measurements in subclinical atherosclerosis
Bengtsson, Anna; Nyman, Emma; Grönlund, Christer; et al.
Reduced progression of carotid intima media thickness by pictorial presentation of subclinical atherosclerosis in VIPVIZA – a randomized controlled trial
Nyman, Emma; Grönlund, Christer; Vanoli, Davide; et al.
Baseline carotid intima media echogenicity is associated with the 3-year progression of intima media thickness
Nyman, Emma; Liv, Per; Wester, Per; et al.
View publications in DiVA

Research projects

29 April 2013 until 31 December 2027
VIPVIZA